Standout Papers

A CFTR Potentiator in Patients with Cystic Fi... 1995 2026 2005 2015 1.5k
  1. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation (2011)
    Bonnie W. Ramsey, Jane C. Davies et al. New England Journal of Medicine
  2. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR (2015)
    Claire Wainwright, J.S. Elborn et al. New England Journal of Medicine
  3. Cystic fibrosis. (1996)
    Pamela B. Davis, Mitchell L. Drumm et al. American Journal of Respiratory and Critical Care Medicine
  4. Inflammatory cytokines in cystic fibrosis lungs. (1995)
    Tracey L. Bonfield, James R. Panuska et al. American Journal of Respiratory and Critical Care Medicine
  5. Effect of High-Dose Ibuprofen in Patients with Cystic Fibrosis (1995)
    Michael W. Konstan, Pamela J. Byard et al. New England Journal of Medicine
  6. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. (1994)
    Michael W. Konstan, Kathleen A. Hilliard et al. American Journal of Respiratory and Critical Care Medicine
  7. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy (2015)
    André M. Cantin, Dominik Hartl et al. Journal of Cystic Fibrosis
  8. A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial (2014)
    Michael Boyle, Scott C. Bell et al. The Lancet Respiratory Medicine

Immediate Impact

3 by Nobel laureates 3 from Science/Nature 90 standout
Sub-graph 1 of 15

Citing Papers

Cystic Fibrosis
2023 Standout
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist
2023 Standout
132 intermediate papers

Works of Michael W. Konstan being referenced

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries
2019
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
and 59 more

Author Peers

Author Last Decade Papers Cites
Michael W. Konstan 14858 2146 2138 2459 234 17.5k
Félix Ratjen 14440 2709 2186 2424 409 17.5k
Margaret Rosenfeld 12408 2128 2408 2072 214 17.0k
Frank J. Accurso 9616 1280 1719 1967 182 12.2k
J.S. Elborn 14769 2040 2739 4012 549 20.5k
Jane C. Davies 8706 1689 1319 2752 332 12.3k
Bonnie W. Ramsey 16111 1635 3371 5404 193 21.0k
Steven M. Rowe 10961 1578 1046 2732 250 14.0k
Bruce C. Marshall 9720 926 2448 1482 136 12.9k
Henry Levison 10149 3329 1347 901 259 13.3k
Mary Corey 8588 1071 1489 1109 156 11.5k

All Works

Loading papers...

Rankless by CCL
2026